These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 28950419

  • 1. Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.
    Jabbour S, Seufert J, Scheen A, Bailey CJ, Karup C, Langkilde AM.
    Diabetes Obes Metab; 2018 Mar; 20(3):620-628. PubMed ID: 28950419
    [Abstract] [Full Text] [Related]

  • 2. Safety profile of dapagliflozin for type 2 diabetes: pooled analysis of clinical studies for overall safety and rare events.
    Ptaszynska A, Johnsson KM, Parikh SJ, de Bruin TW, Apanovitch AM, List JF.
    Drug Saf; 2014 Oct; 37(10):815-29. PubMed ID: 25096959
    [Abstract] [Full Text] [Related]

  • 3. Hypersensitivity Events, Including Potentially Hypersensitivity-Related Skin Events, with Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.
    Mellander A, Billger M, Johnsson E, Träff AK, Yoshida S, Johnsson K.
    Clin Drug Investig; 2016 Nov; 36(11):925-933. PubMed ID: 27461213
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study.
    Hong JH, Kim MJ, Min KW, Won JC, Kim TN, Lee BW, Kang JG, Kim JH, Park JH, Ku BJ, Lee CB, Kim SY, Shon HS, Lee WJ, Park JY.
    Diabetes Obes Metab; 2025 Jan; 27(1):81-91. PubMed ID: 39375869
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus.
    Schernthaner G, Barnett AH, Emser A, Patel S, Troost J, Woerle HJ, von Eynatten M.
    Diabetes Obes Metab; 2012 May; 14(5):470-8. PubMed ID: 22268497
    [Abstract] [Full Text] [Related]

  • 11. Analysis of Fractures in Patients With Type 2 Diabetes Treated With Empagliflozin in Pooled Data From Placebo-Controlled Trials and a Head-to-Head Study Versus Glimepiride.
    Kohler S, Kaspers S, Salsali A, Zeller C, Woerle HJ.
    Diabetes Care; 2018 Aug; 41(8):1809-1816. PubMed ID: 29907581
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studies.
    Pratley R, Dagogo-Jack S, Charbonnel B, Patel S, Hickman A, Liu J, Tarasenko L, Pong A, Ellison MC, Huyck S, Gantz I, Terra SG.
    Diabetes Obes Metab; 2020 Dec; 22(12):2276-2286. PubMed ID: 32700421
    [Abstract] [Full Text] [Related]

  • 13. The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
    McEwan P, Gabb PD, Davis JA, Garcia Sanchez JJ, Sjöström CD, Barone S, Kashioulis P, Ouwens M, Cassimaty S, Correa-Rotter R, Rossing P, Wheeler DC, Heerspink HJL.
    Nephrol Dial Transplant; 2024 Nov 27; 39(12):2040-2047. PubMed ID: 38730538
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.
    Chung S, Ben-Menachem E, Sperling MR, Rosenfeld W, Fountain NB, Benbadis S, Hebert D, Isojärvi J, Doty P.
    CNS Drugs; 2010 Dec 27; 24(12):1041-54. PubMed ID: 21090838
    [Abstract] [Full Text] [Related]

  • 16. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA, Pawsey SP, Campbell JC, Hu X.
    Gend Med; 2010 Apr 27; 7(2):88-108. PubMed ID: 20435272
    [Abstract] [Full Text] [Related]

  • 17. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK.
    Cochrane Database Syst Rev; 2019 Aug 06; 8(8):CD010233. PubMed ID: 31425621
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus.
    Nauck M, Araki A, Hehnke U, Plat A, Clark D, Khunti K.
    Int J Clin Pract; 2018 Oct 06; 72(10):e13240. PubMed ID: 30216648
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.